The possibility has arisen within the last three decades that major diseases that directly affect humankind worldwide may be preventable by the simple improving the dietary intake of those nutrient substances that have become called “antioxidant nutrients”.
There is no doubt that successful prevention is the key to controlling morbidity and mortality from chronic diseases affecting humankind. Prevention provides: the methods to avoid occurrence of disease and most population-based health promotion efforts are of this type; methods to diagnose and treat extant disease in early stages before it causes significant morbidity; methods to reduce negative impact of extant disease by restoring function and reducing disease-related complications; and finally, the methods to mitigate or avoid results of unnecessary or excessive interventions in the health system.
The quality and quantity of diet with respect to the intake of fresh food (fruits, seeds and vegetables) may improve our health and consequently decrease the risk of any disease. Currently, the antioxidant nutrients are the vitamins C and E and β-carotene. However, it is worthy to mention that these compounds are involved in other functions a part from being antioxidant nutrients.
Selenium (Se), a trace mineral. Is the 34th element and is located between sulfur and tellurium in Group 16 in the periodic table. It is a nonmetallic element and its properties are intermediate between adjacent sulfur and tellurium. It was originally discovered by a German chemist Martin Heinric Klaproth, but misidentified as tellurium. Later, in 1818 a Swedish chemist Jons Jacob Berzelius discovered selenium and was named after the Greek goddess of the moon, Selene  and its name was associated with tellurium, a name for earth. He observed the element as a deposit following the oxidation of sulfur dioxide from cooper pyrites. It ranks seventieth in abundance among the elements and is distributed in the Earth’s crust at concentrations averaging 0.09 mg/kg . Selenium has six major stable isotopes have been reported and the most abundant in nature are 80Se (49.6%) and 78Se (23.8%) . In general, selenium is present in the environment in elemental form or in the form of selenide (Se2-), selenate (SeO42-), or selenite (SeO32-). The identity and amounts of the various oxidation-state species in soils depends enormously on the redox-potential conditions. The lower oxidation states predominate in anaerobic conditions, acidic soils, and the higher oxidation states are favored in alkaline and aerobic conditions. Both selenites and selenates are taken up by plants and converted to protein-bound selenocysteine and selenomethionine, soluble inorganic forms, several free amino acids, and volatile organoselenium compounds. The elemental form of selenium, selenium dioxide, and volatile organoselenium compounds produced by industries and plants are incorporated in the environment. Selenium occurs naturally in water in trace amounts as a result of geochemical processes, such as weathering of rocks and erosion of soils, and is usually present in water as selenate or selenite; however the elemental form may be carried in suspension .
Interest in selenium and health was focused primarily on the potentially toxic effects of high intakes in humans, stimulated by reports of alkali disease in livestock raised in seleniferous areas, in the last century . Selenium is a trace mineral that is essential to good health but required only small amounts [6,7]. Selenium is considered as essential human micronutrient and is incorporated into proteins to make selenoproteins. Selenium is present in the selenoproteins, as the aminoacid selenocysteine (Se-Cys) [8-12].
Dietary levels of the desired amount of Se are in a very narrow range: consumption of foods containing less than 0.1 mg kg-1 of this element will result in Se deficiency, whereas dietary levels above 1 mg kg-1 will lead to toxic manifestations . Se status varies significantly across different populations and different ethnic groups [14-15].
Selenium enters the food chain through plants, and the amount and bioavailability of selenium in the soil typically reflects the plant level. Selenium is provided by the diet in humans, but may also be provided from drinking water, environmental pollution, and in recent years through supplementation [16,17]. Plants convert Se mainly into selenomethionine (Se-Met) and incorporated it into protein place of methionine. More than 50% of the total Se content of the plant exist as Se-Met, the rest exist as selenocysteine (Se-Cys), methyl-Se-Cys and c-glutamyl-Se-methyl-Cys. The later compounds are not significantly incorporated into plant protein. Higher animals are unable to synthesize Se-Met and only Se-Cys was detected in rats supplemented with Se as selenite . Animals that eat grains (Brazil nuts, sunflower seeds, walnuts and grains) that were grown in selenium rich soil have higher levels of selenium in their muscles, liver, kidney, heart, spleen and fingernails. Other natural selenium sources are butter, eggs, brewer’s yeast, wheat germ, garlic, raspberry leaf, radish, horseradish, onions, shellfish, broccoli, fennel seed and ginseng, among other sources.
Most ingested forms of selenium ultimately are metabolized to low molecular weight inorganic and organic compounds that play a central role in human health either via incorporation into selenoproteins or binding to selenium binding proteins . Therefore, a tremendous effort has been directed toward the synthesis of stable organoselenium compounds that could be used as antioxidants, enzyme modulators, antitumor, antimicrobials, antihypertensive agents, antivirals and cytokine inducers. Several excellent books and reviews appeared in literature describing the biological function of organoselenium compounds [20-22].
The role of organoselenium compounds as antioxidants, as enzyme modulators, photo-chymotherapeutic agents, cytokine inducers and immunomodulators, and antihypertensive and cardiotonic agents have been recently described in literature .
The essentiality of selenium results as a necessary component of the active center of a number of selenoenzymes. Selenium functions as a redox center. The term selenoprotein is any protein that includes in its primary sequence of amino acids, the selenocysteine (Se-Cys) residue . There are at least 30 selenoproteins that have been identified in mammals, and it has been estimated that humans have about 25 selenoproteins, including glutathione peroxidase, thioredoxin reductase, iodothyronine, deiodinase, and selenoproteins P, W, and R [25-27]. GPx accounts for 10–30% of plasma selenium, and selenoprotein P accounts for another 50% . These enzymes protect cells from free radical damage and regulate DNA transcription and cell proliferation. The glutathione and thioredoxin systems in particular have long been considered the major pathways through which selenium exerts its potential chemopreventive effect , while some investigations have also suggested growth inhibitory, proapoptotic activity for selenometabolites in premalignant cells . Selenium is also involved in thyroid function, T cell immunity, and spermatogenesis , and is a competitive antagonist of potentially carcinogenic heavy metals such as arsenic and cadmium .
The organism has several biological defense mechanisms against intracellular oxidative stress such as superoxide dismutase, catalase, glutathione peroxidase and nonenzymatic antioxidants such as glutathione, vitamins A, C and E, riboflavin, a B vitamin and selenium can also contribute to overcome oxidative stress .
Vitamin E is a fat-soluble vitamin known for its antioxidant capacity that is why it is well known as a lipophilic antioxidant that protects membranes from being oxidatively damaged as an electron donor to free radicals . Vitamin E belongs to a group of the eight naturally occurring vitamer forms, four tocopherols (α, β, γ, δ) and four tocotrienols (α, β, γ, δ) based on the hydroxyl and methyl substitution in their phenolic rings, all of which have saturated and three double bonds in their phytyl tails. α-tocopherol (from the Greek
It is well known that all forms of vitamin E are lipid soluble they easily absorbed from the intestinal lumen after dietary intake via micelles created by biliary and pancreatic secretions [34-35]. Vitamin E is then incorporated into chylomicrons and secreted into the circulation where, transported by various lipoproteins, it travels to the liver . Plasma α-tocopherol concentrations in humans range from 11 to 37 μmol/L, whereas γ-tocopherol are between 2 and 5 μmol/L. The liver plays a central role in regulating α-tocopherol levels by directly acting on the distribution, metabolism, and excretion of this vitamin . The major hepatic regulatory mechanism is the α-tocopherol transfer protein, α-TTP, which has been identified in a variety of mammals, including humans . This protein facilitates secretion of α-tocopherol from the liver into the bloodstream, by acquiring it from endosomes and then delivering it to the plasma membrane where it is released and promptly associates with the different nascent lipoproteins . Plasma concentration of vitamin E depends completely on the absorption, tissue delivery, and excretion rate. The estimated α-tocopherol half-life in plasma of healthy individuals is ~ 48 to 60 H, which is much longer than the half-life of γ-tocopherol approximately 15 H. These kinetic data underscore an interesting concept that while α-tocopherol levels are maintained, the other forms of vitamin E are removed much more rapidly .
2. Selenium and Health
Selenium deficiency is associated with the pathogenesis of wide variety of processes that affects our health and disease including the antioxidant activity, depression, allergies, preventing oxidative stress, HIV infection, in the brain, thyroid metabolism, cancer, diabetes mellitus, male fertility, asthma, cardiovascular disorders, rheumatoid arthritis, pre-eclampsia, in immune function, in alleviate bone impairments, aging, gastrointestinal problems, selenium interactions and toxicity, anti-inflammatory effects, and hypertension. The list of clinical disorders expected to be influenced by Se deficiency is rapidly growing with time. Some selected issues regarding the role of Se in health and disease have been briefly outlined as follows:
2.1. Se and antioxidant activity
Selenocysteine is recognized as the 21st amino acid, and it forms a predominant residue of selenoproteins and selenoenzymes in biological tissues. The molecular structure of selenocystiene is an analogue of cysteine where a sulphur atom is replaced by Se. Even though Se and sulphur share some similar chemical properties, there are also some differences. The R-SeH with a pKa 5.2 is more is more acidic than R-SH with a pKa 8.5, and readily dissociated at physiological pH, which may contribute to its biological reactivity. In the body, both organic [selenocysteine(SeCys) and selenomethionine (SeMet)] and inorganic (selenite, selenate) Se compounds are readily metabolized to various forms of Se metabolites . Of particular importance during this metabolic process is the formation of hydrogen selenide (H2Se) from selenite after the action of glutathione-coupled reactions
2.2. Se and depression
In  selenium’s function as an antioxidant, and as a constituent of selenoproteins that are important in redox homeostasis, warrants further investigation as a risk factor for depression, and suggest a potentially novel modifiable factor in the primary prevention and management of depression. Depression is becoming recognized as an inflammatory disorder, accompanied by an accumulation of highly reactive oxygen species that overwhelm usual defensive physiological processes [47-51]. Several indicators support a role for selenium in normal brain function. During times of selenium deficiency, there is preferential storage of selenium in the brain . Selenium has significant modulatory effects on dopamine  and dopamine plays a role in the pathophysiology of depression and other psychiatric illnesses . Diminished levels of selenium in the brain are associated with cognitive decline  and Alzheimer’s disease . Selenium supplementation has been linked with improvements in mood  and protection against postpartum depression . What is unclear is if low dietary selenium is a risk factor for the development of depression. In recognition of selenium’s biological activity, it has been hypothesized that low levels of dietary selenium would be associated with an increased risk of major depressive disorder (MDD) in a representative population-based sample of women.
Alterations in redox biology are established in depression; however, there are no prospective epidemiological data on redox-active selenium in depression. It is known that selenium’s function as an antioxidant, and as a constituent of selenoproteins that are important in redox homeostasis, warrants further investigation as a risk factor for depression, and suggest a potentially novel modifiable factor in the primary prevention and management of depression.
2.3. Selenium and allergies
The International Study of Asthma and Allergies in Childhood (ISAAC) found that one in four New Zealand children aged 6–7 years had experienced asthma symptoms, which placed New Zealand in the top four countries for asthma prevalence . The reasons for the high prevalence and severity of this condition or the increased prevalence of asthma over the last 20 years are not well understood. One of a number of environmental factors that have been proposed as a reason for the escalation in asthma prevalence is a decreasing intake of dietary antioxidants . It is well known that selenium is essential for the optimal functioning of the selenoenzymes glutathione peroxidases (GPx) and thioredoxin reductases, powerful antioxidants, and is found abundantly in lung tissue and the extracellular fluid of the respiratory system . Selenium has been implicated in inflammation by reducing the severity of the inflammatory response through modulation of the pro-inflammatory leukotrienes, important mediators of acute asthmatic reactions as well as sustaining the inflammatory process causing a late allergic reaction metabolism . Evidence from randomized controlled trials  and basic mechanistic work investigating the effect of selenium on markers of inflammation and oxidative stress . Evidences have supported a protective role for selenium in asthma, although other studies have not [64-66]. The ISAAC study does not support a strong association between selenium status and the high incidence of asthma in New Zealand. However, there was a modest association between lower plasma selenium and whole blood glutathione peroxidase activity and higher incidence of persistent wheeze .
2.4. Selenium in preventing oxidative stress
The reactivity of organoselenium compounds [22,68] characterized by high nucleophilicity and antioxidant potential, and provides the basis for their pharmacological activities in mammalian models. Organochalcogens have been widely studied given their antioxidant activity, which confers neuroprotection, antiulcer, and antidiabetic properties. Given the complexity of mammalian models, understanding the cellular and molecular effects of organochalcogens has been hampered. In reference  the nematode worm
Bone is a specialized connective tissue, which forms the framework of the body. Various physiological conditions can adversely affect femoral bone metabolism. These physiological conditions could be food deprivation , and iodine and/or selenium (Se) deficiency [71,72] and antithyroid drugs  affects bone maturation. Selenium is an important protective element that may be used as a dietary supplement protecting against oxidative stress, cellular damage and bone impairments .
2.5. Selenium in HIV infection
The HIV pandemic has placed a great demand upon the scientific community to develop effective prevention and treatment methods. Since the beginning of the pandemic in 1981, over 25 million people are estimated to have died from the disease . It is currently a leading cause of death in many parts of the world, and a disease that disproportionately affects the marginalized and socially disadvantaged. It is currently a leading cause of death in many parts of the world, and a disease that disproportionately affects the marginalized and socially disadvantaged. Many of those affected also suffer from chronic food insecurity and malnutrition, so therapies that could potentially target both HIV disease and malnutrition, such as multivitamins, have been extensively researched for potential benefits . Among such therapies, the antioxidant micronutrients theorized to have potential benefits in HIV disease, apart from correcting deficiencies, have been examined frequently [77,78].
Selenium has an inhibitory effect on HIV in vitro through antioxidant effects of glutathione peroxidase and other selenoproteins. Numerous studies have reported low selenium status in HIV-infected individuals, and serum selenium concentration declines with disease progression. Some cohort studies have shown an association between selenium deficiency and progression to AIDS or mortality. In several randomized controlled trials, selenium supplementation has reduced hospitalizations and diarrheal morbidity, and improved CD4+ cell counts, but the evidence remains mixed. Additional trials are recommended to study the effect of selenium supplementation on opportunistic infections, and other HIV disease-related comorbidities in the context of highly active antiretroviral therapy in both developing and developed countries .
2.6. Selenium in the brain
In addition to the well-documented functions of Se as an antioxidant and in the regulation of the thyroid and immune function . Recent advances have indicated a role of Se in the maintenance of brain function . Selenium is widely distributed throughout the body, but is particularly well maintained in the brain, even upon prolonged dietary Se deficiency . In the brain, the highest concentration of Se is found in the gray matter, an area responsible for chemical synaptic communication . It has been shown that rats on a Se-deficient diet for thirteen weeks retained Se in their brain, while their plasma Se concentrations were depleted . After intraperitoneal injection of 75SeO32- into Se-deficient rats, the brain rapidly sequesters a large portion of the available Se . In the brain, it was found that the cerebellum accumulated the highest concentration of Se, followed by the cortex, medulla oblongata, cerebral hemisphere, and the spinal cord. Interestingly, Se retention in the brain depends on Selenoprotein P expression . Because the body preferentially allocates available Se to the brain during Se deficiency, Se may play an essential role in the brain. More evidence for the brain being at the apex of Se retention is provided by a study showing that a six generation Se deficiency in rats caused a more than 99% reduction of Se concentration in the liver, blood, skeletal tissue, and muscle, while the brain retained a 60% of the Se . Se concentration in Alzheimer’s brains was found to be 60% of the age-matched control individuals . Accumulated lines of evidence indicate important roles of selenoproteins in the maintenance of optimal brain functions via redox regulation. Decreased expression of several selenoproteins is associated with the pathologies of a few age-associated neurodisorders, including Parkinson’s disease, Alzheimer’s disease and epilepsy .
Oxidative stress and generation of reactive oxygen species are strongly implicated in a number of neuronal and neuromuscular disorders, including epilepsy. The functions of selenium as an antioxidant trace element are believed to be carried out by selenoproteins that possess antioxidant activities and the ability to promote neuronal cell survival . It is known the role of selenium in a detoxifying enzyme, glutathione peroxidase, this element has been demonstrated to have a positive biological function in various aspects of human health . Oxidative stress and generation of reactive oxygen species are strongly implicated in a number of neurologic disorders including seizure disorders. Oxidative phosphorylation occurring in the mitochondria produces oxygen radicals routinely in all tissues as well as the nervous system. One important defense may be to remove the oxygen radicals. Selenium-requiring processes are involved in normal maintenance of cell function. However, when the system is overused or chronically activated beyond its normal state, such as recurrent or intractable seizures, abnormal increases in by-products can produce neuronal cell damage. Selenium provides protection from reactive oxygen species–induced cell damage. The proposed mechanisms are mainly through the functions of seleno-dependent enzymes and selenoproteins [82,91]. It seems that selenium plays an important role in stopping the vicious cycle of oxidative stress and neuronal damage in patients with intractable seizures by restoring the defense mechanism.
2.7. Selenium and the thyroid
Some selenoproteins of the human selenoproteome display multiple genes performing similar functions. The main selenoprotein families are the glutathione peroxidases (GPxs; seven genes), the thioredoxin reductases (TRxs; three genes) and the iodothyronine deiodinases (DIs; three genes) [92,93]. The GPxs, which possess oxidoreductase functions, protect the cell from oxidative stress. The TRxs form a cellular redox system, existing in many organisms, which is essential for cell development and proliferation. The DIs that catalyzes the conversion of T4 to T3 provides the sources of T3 production. It may thus be hypothesized that the essential micronutrient selenium, in the form of Se-Cys, modulates redox-sensitive signaling pathways and thereby potentially modifies selenoprotein gene expression. These findings have aroused growing interest of the scientific community in this multifaceted element. In this context, whereas selenium administration for cancer chemoprevention produced questionable results, those of selenium supplementation in patients with autoimmune thyroid disease have been more encouraging. In  comprises an in-depth discussion of the link between selenium and thyroid function; it provides a critical analysis of the data contained in recent studies, an update and evaluation of current knowledge with regard to the mechanisms of action of selenium, and reflections on the prospects for selenium supplementation in thyroid pathology.
Evidence in support of selenium supplementation in thyroid autoimmune disease is evaluated; the results herein presented demonstrating the potential effectiveness of selenium in reducing the antithyroid peroxidase titer and improving the echostructure in the ultrasound examination. However, considerable discord remains as to who should comprise target groups for selenium treatment, who will most benefit from such treatment, the precise impact of the basal antithyroid peroxidase level, and the effect of disease duration on the treatment outcome. Clearly, further in-depth studies and evaluation are required concerning the mechanism of action of selenium as well as the choice of supplements or dietary intake.
2.8. Selenium in cancer
The reactive oxygen species (ROS) are derived from cellular oxygen metabolism and from exogenous sources. An excess of ROS results in oxidative stress and may eventually cause cell death. ROS levels within cells and in extracellular body fluids are controlled by concerted action of enzymatic and non-enzymatic antioxidants. The essential trace element selenium exerts its antioxidant function mainly in the form of selenocysteine residues as an integral constituent of ROS-detoxifying selenoenzymes such as glutathione peroxidases (GPx), thioredoxin reductases (TrxR) and possibly selenoprotein P (SeP). In particular, the dual role of selenoprotein P as selenium transporter and antioxidant enzyme is highlighted herein. A cytoprotective effect of selenium supplementation has been demonstrated for various cell types including neurons and astrocytes as well as endothelial cells. Maintenance of full GPx and TrxR activity by adequate dietary selenium supply has been proposed to be useful for the prevention of several cardiovascular and neurological disorders. On the other hand, selenium supplementation at supranutritional levels has been utilized for cancer prevention: antioxidant selenoenzymes as well as prooxidant effects of selenocompounds on tumor cells are thought to be involved in the anti-carcinogenic action of selenium [95,96].
Among various antioxidant minerals, selenium it may prove to be of major significance as a prophylactic agent against cancer. Low blood selenium concentration and incidence of carcinogenesis have been well observed in both animals  as well as in human studies . In addition, it has been demonstrated in a double blind randomized cancer prevention trial in humans that increased selenium intake has a significant role in the treatment of cancer . A similar prospective study could also be designed for other cancers to determine the chemopreventive effect of Se. Selenium has also been reported to have a beneficial effect on the incidence of gastrointestinal and bladder cancers [100,101].
Although selenium is reported to play a significant role in cancer development, its exact anticancer mechanism of action at molecular levels is not fully understood. However, it has been hypothesized that the most possible mechanistic action of Se as chemoprevention is its role in the antioxidant defense systems to reduce oxidative stress and limit DNA damage [24,102]. Experiments carried out within the framework of a canine model using male beagle dogs to mimic prostate cancer in humans showed that the damage to DNA was significantly reduced when the animals were exposed to increased Se dietary supplements . The effectiveness of Se in the prevention of DNA damage, however, depends on its chemical forms. In an
In  knowledge of the plasma selenium levels are associated with optimized concentration or activity of specific selenoproteins can provide considerable insights from epidemiological data on the possible involvement of those selenoproteins in health, most notably with respect to cancer. For cohort studies, if selenoproteins such as glutathione peroxidase and selenoprotein P are relevant to cancer, one might only expect to see an effect on risk when the concentrations in the cohort range from below, to above, the level needed to optimize the activity or concentration of these enzymes. Similarly, trials would only show a beneficial effect of supplementation if selenium status were raised from below, to above, the optimal concentration for the selenoproteins likely to be implicated in cancer risk, as occurred in the Nutritional Prevention of Cancer (NPC) trial but not in Selenium and Vitamin E Cancer Prevention Trial (SELECT). The most powerful evidence for the involvement of selenoproteins in human health comes from epidemiological studies that have related single nucleotide polymorphisms in selenoproteins to disease risk. The totality of the evidence currently implicates GPx1, GPx4, SEPS1, Sep15, SEPP1 and TXNRD1 in conditions such as cardiovascular disease, pre-eclampsia and cancer. Future studies therefore need to determine not only selenium status, but genotype, both in selenoproteins and related pathways, when investigating the relationship of selenium with disease risk.
2.9. Selenium in diabetes
The evidence supporting an effect of selenium on the risk of diabetes is variable, occasionally conflicting, and limited to very few human studies. Following a trial investigating the effect of selenium supplementation (200 μg/day) on skin cancer, subsequent analysis showed that there was an increased risk of developing type 2 diabetes in the supplemented group. Evidence from analysis of NHANES III  supports these findings; the adjusted mean serum selenium concentrations were slightly, but significantly, higher in diabetics compared with those without the disease. This study, conducted in an elderly French population, found a sex-specific protective effect of higher selenium status at baseline on later occurrence of dysglycemia; that is, risk of dysglycemia was significantly lower in men with plasma selenium, but no significant relationship was observed in women .
The role of selenium as an antioxidant, particularly within the GPxs, selenium is likely to be important in reducing oxidative stress, an important risk factor for developing diabetes. There are also plausible suggestions that selenium can influence glucose metabolism. However, at high intakes it is also conceivable that reactive oxygen species could be generated or selenium may accumulate in the organs associated with glucose metabolism . In patients with diabetes, selenium supplementation (960 μg/day) reduced NF-κB levels to those comparable with nondiabetic controls . In addition, further analysis of the Nutritional Prevention of Cancer trial data has shown an increased risk of self-reported Type-2 diabetes in those supplemented with Se, though the effect was significant only in those in the top tertile of plasma Se at baseline .
2.10. Selenium and male fertility
Selenoprotein P transports selenium particularly to testis and brain . Among the five enzymes of GPx, GPx1 prevents apoptosis induced by oxidative stress and GPx4 acts directly on membrane phospholipid hydroperoxides and detoxifies them. Selenium as GPx, is present in spermatids and forms the structural part in the mid piece of mature spermatozoa. Some well known effects of selenium deficiency include instability of the middle piece leading to defective sperm motility , low reproductive ability and abnormal development of spermatozoa . Selenium is also required for testosterone synthesis and sequential development of flagella . It can restore the physiological constitution of polyunsaturated fatty acid in the cell membrane . Testes are extremely resistant to Se depletion and have high Se content. Recent studies have shown that sperm and testicular Se was unaffected by the supplementation, suggesting that testes are protected from Se excess as well as from Se deficiency .
2.11. Selenium in asthma
Se status is decreased in patients with asthma, as is activity of glutathione peroxidase in platelets and erythrocytes. There is an associated marked oxidant/antioxidant imbalance in the blood of asthmatics, which reflects poor antioxidant status and enhanced inflammatory mediated oxidative stress . According to the University of Maryland Medical Center, a 2004 study of 24 asthmatics that were given selenium supplements for 14 weeks had significant improvement in their symptoms when compared to a control group given a placebo. Although this is a small study done over a short amount of time, it's encouraging .
2.12. Selenium in cardiovascular disorders
Free radicals are toxic to the myocardium and can cause tissue damage that leads to extensive necrosis, myocytolysis and cellular edema . Atherosclerotic plaque formation may be a reflection of sub-optimal GPx4 activity in the prevention of LDL oxidation, with subsequent uptake by endothelial cells and macrophages in arterial blood vessels . Selenium via GPx reduces phospholipids, hydro peroxides and cholestryl esters associated with lipoproteins and may therefore, not only reduce the accumulation of oxidized LDL in arterial wall but also reduce platelet aggregation and activation of monocyte and macrophages . Selenium owing to its antithrombotic effect on the interaction between platelets and endothelial cells via GPx, also provides concrete evidence in the prevention of atherosclerosis .
The study on acute myocardial infarction (AMI) patients, it was observed that selenium dependent GPx level decreases significantly in AMI patients and explained it as an imperative consequent of GPx activity in annihilating oxygen toxicity by metabolizing H2O2 and inhibiting further free oxygen radical production in early phase of myocardial infarction .
2.13. Selenium in rheumatoid arthritis
Scientific research shows that people with rheumatoid arthritis have low levels of selenium. A study suggests, it is part of the body's defense mechanism . In reference  the authors found lower selenium levels in patients with rheumatoid arthritis who were treated with arthritis medication compared with people without the condition. In people without rheumatoid arthritis or a family history of the condition, low levels of the mineral may increase the risk of developing rheumatoid arthritis .
2.14. Selenium in pre-eclampsia
In reference , pre-eclampsia (pregnancy induced hypertension; PIH), is an important cause of maternal morbidity and mortality with essentially unknown etiology. However, the precise factors involved in the pathogenesis of PIH are still unknown . It has been conceived that free radical mediated oxidative stress may contribute to the development of pre-eclampsia. Selenium and its related enzymes especially GPx play a crucial role in annihilating oxygen toxicity and there by controlling the progression of disease . In addition, selenium deficiency in women may result in infertility, miscarriages and retention of the placenta .
2.15. Selenium in immunity
In reference , the generation of ROS in a limited dose is one of the processes induced by the immune system to destroy microbial pathogens and viruses. However, the over-production of ROS can also cause damage to the host cells that need to be protected by Se at various stages in the immune system. Keshan disease, an endemic cardiomyopathy in China that develops as a result of Se deficiency, may also be complicated with viral infection, and this has led to the investigation of the effects of viruses, such as coxsackievirus, on Se-deficient animals [131,132]. Results from animal studies have demonstrated that Se deficiency can lead to an impairment of immune functions that result in the inability of phagocytic neutrophils and macrophages to destroy antigens. A low Se status in humans has been reported to cause a decreased immune response to poliovirus vaccination . This study also demonstrated that the subjects supplemented with Se showed fewer mutations in poliovirus than those who received a placebo. The involvement of Se in the immune system may be associated with a number of mechanisms, including the increased activity of natural killer (NK) cells, the proliferation of T-lymphocytes, increased production of interferon c, increased high-affinity interleukin-2 receptors, stimulation of vaccine-induced immunity and increased antibody-producing B-cell numbers [134,135].
2.16. Selenium in bone impairments
Osteoblasts (bone-forming cells) and osteoclasts (bone-resorption cells) are involved in bone remodeling. Therefore, any loss of osteoblastic activity or an increase in osteoclastic activity could lead to a decrease in bone-mineral densities (BMD), bone mass, and make the bones more likely to osteoporosis, and ultimately to fractures . In addition, high levels of reactive oxygen species (ROS) and many other factors such as genetic race, hormonal, mechanical, and nutritional statues are involved in bone weakness and fractures. ROS shift cells into a state of oxidative stress  which contributes to the etiology of various degenerative diseases that cause tissue injury [136,137]. Studies have demonstrated that the ischemia-reperfusion processes that occur after a fracture are associated with oxidative stress development [136,138]. It is believed that bone markers such as osteocalcin and alkaline phosphatase as well as antioxidant enzymes play a significant role in fracture healing. However, to the best of our knowledge, there are no reports about the use of vitamins A, C, E, and selenium as antioxidant therapy to explore their effects in the levels of bone-healing markers and oxidative stress parameters of osteoporotic patients. In  suggests that selenium is an important protective element that may be used as a dietary supplement protecting against bone impairments.
3. Vitamin E and Health
3.1. Vitamin E
All forms of vitamin E meet the chemical definition of an antioxidant moiety: ‘‘chain-breaking free radical scavenger.’’ Indeed consistent data have shown that all isoforms act as potent antioxidants in conventional in vitro paradigms. The free hydroxyl group on the aromatic ring is thought to be responsible for this property, and a relatively stable form of the original vitamin E is formed when hydrogen from this group is donated to a free radical. Yet, definitive proof that vitamin E possesses antioxidant properties has been hampered for a long time because of a lack of sensitive and specific analytical techniques to measure this biologic event
One of the major vitamin E-deficiency symptoms are neurological disorders. Furthermore, vitamin E deficiency is related to female infertility. The frame to pinpoint the physiological action of vitamin E is set by its chemical nature: (i) It is a redox-active compound prone to undergo 1- and 2-electron transitions and (ii) it is highly lipophilic, although this property may be modulated by phosphorylation . In  oxidative stress is a developing research field and is being examined in female infertility. Prooxidants, also called free radicals or reactive oxygen species (ROS), and their neutralizing agents the antioxidants are the main chemicals of the oxidation mechanism. The term oxidative stress refers to the dysequilibrium between the free radicals and the antioxidants in favor of the free radicals. In actuality, free radicals are not so frightening, since they are necessary for the adequate reproductive functions within the ovary and the endometrium. Vit E administration may improve the endometrial response in unexplained infertile women
Some non-antioxidant properties of vitamin E could play a key role in neuroprotection. It has been recently shown that α-tocotrienol, at nanomolar concentrations, protects mouse hippocampal and cortical neurons from cell death by modulating neurodegenerative signaling cascades. Furthermore, it has been shown that α-tocotrienol modulates 12-lipoxygenase and phospholipase A2 activities, which are implicated in glutamate-induced neuronal cell death . Some vitamin E forms (α- and γ-tocopherol, tocotrienols) also exhibit potent anti-inflammatory properties [144,145]. The introduction of the free radical theory of brain aging has propelled a renewed interest in this vitamin. As result, by preventing and/or minimizing the oxidative stress dependent brain damage, this vitamin plays important role in brain aging, cognition, and Alzheimer’s dementia.
Vitamin E is a potent peroxyl radical scavenger that prevents lipid peroxidation  and is found in high concentrations in immune cells . Deficiency in vitamin E is associated with increased oxidative stress  and impaired immune function, including both humoral and cell-mediated immunity, phagocyte function, and lymphocyte proliferation . Age-related declines in immune function can be restored by vitamin E supplementation . This vitamin is an exogenous, lipidsoluble antioxidant molecule. It is thought to be a direct free radical scavenger by activating the intracellular antioxidant enzymes and saving the cell membranes from lipid peroxidation, which was demonstrated on sperm membrane components . Its antioxidant effect was concluded in cancer therapy, high-risk pregnancy and male infertility [152-154].
Vitamin E (α−tocopherol acetate) is found within the phospholipid bilayer of cell membranes where it functions as an electron donor to free radicals. It has been recognized as one of the body’s major natural antioxidants. Another antioxidant, Se appears to function as an antimutagenic agent, preventing the malignant transformation of normal cells. Its protective effects seem to be primarily associated with its presence in the seleno-enzymes which are known to protect DNA and other cellular components from oxidative damage .
Selenium, vitamin A (retinol) and vitamin E (α-tocopherol) are essential micronutrients for human health. Both selenium and vitamin E are important in host antioxidant defense and immune function. It has been reported that deficiency of selenium and vitamins may promote peroxidation events leading to the release of free radicals. All have free-radical-scavenging properties that allow them to function as physiologic antioxidants in protecting a number of chronic diseases, such as cancer and cardiovascular disease. In addition to its antioxidant capacity, α-tocopherol regulates expression of genes involved in a wide range of cell functions, including cell cycle regulation, inflammation and cell adhesion, cell signaling, and lipid uptake .
Selenium also has an important role in antioxidant defense and immune function. Due to its incorporation as selenocysteine into glutathione peroxidase (GPX)  and thioredoxin reductase , selenium is important for the control of oxidative stress and, therefore, the redox tone of the cell. In total, there are 25 identified selenoproteins (24 in rodents), many with unknown function . Selenium is important for cytotoxic T-lymphocyte and natural killer cell activity , respiratory burst , and protection against endotoxin-induced oxidative stress . Multiple studies have shown that NF-kB activation can be affected by selenium status [161,162], and selenium deficiency can alter chemokine and cytokine expression during viral infections . Various investigators have reported the role of selenium as an inhibitor of carcinogenesis in various organs including liver, skin, stomach, mammary gland, gastrointestinal and oral cavity [164,165].
In  blader cancer represents an important cause of morbidity and mortality. In 2010 it was again the second most common genitourinary cancer in the United States with an established 70,530 new cases and 14,680 deaths . Currently it is estimated that more than 500,000 men and women in the United States have a history of bladder cancer. The etiology of most bladder urothelial carcinoma is associated with tobacco exposure, occupational exposure to aromatic amines, and exposure to the chemical and rubber industries . Bladder cancer is the most expensive cancer in the United States, accounting for almost $3.7 billion (2001 value) in direct costs . There is substantial epidemiological and biological evidence that selenium and vitamin E may prevent bladder cancer. A recent meta-analysis of 7 published epidemiological studies, including 3 case-control, 3 nested case-control and 1 case cohort series, examined the association between selenium levels and bladder cancer . In the analysis stratified by gender only women showed a significantly decreased risk associated with selenium. An opposite gender pattern, with protective effects in men but not in women, was reported in a meta-analysis of selenium supplementation, primary cancer incidence and mortality . Epidemiological and biological evidence suggests a preventive effect of selenium and vitamin E on bladder cancer. These researches assessed the effect of selenium and/or vitamin E on bladder cancer development.
3.2. Selenium and vitamin E
Selenium and vitamin E are essential components of the human diet and have been studied as antioxidants and/or potential agents for a variety of human diseases. Various formulations of both selenium and vitamin E have been shown to possess a therapeutic and preventive effect against prostate cancer. The Selenium and Vitamin E Cancer prevention Trial (SELECT) started in 2001 and was a phase III, randomized placebo/controlled human trial to investigate the prostate cancer chemopreventive effects of selenium and vitamin E or their combination [172,173].
Sselenium an essential trace element, and vitamin E, a lipid soluble antioxidant, are important mediators for protection against oxidative stress. Deficiencies in either Se or vitamin E result in increased viral pathogenicity and altered immune responses. Furthermore, deficiencies in either Se or vitamin E results in specific viral mutations, changing relatively benign viruses into virulent ones. Thus, host nutritional status should be considered a driving force for the emergence of new viral strains or newly pathogenic strains of known viruses .
Several studies have evaluated the possible association between antioxidants vitamins or selenium supplement and the risk of prostate cancer, but the evidence is still inconsistent. We systematically searched PubMed, EMBASE, the Cochrane Library, Science Citation Index Expanded, Chinese biomedicine literature database, and bibliographies of retrieved articles up to January 2009. We included 9 randomized controlled trials with 165,056 participants; methodological quality of included trials was generally high. Meta-analysis showed that no significant effects of supplementation with β-carotene (3 trials), vitamin C (2 trials), vitamin E (5 trials), and selenium (2 trials)versus placebo on prostate cancer incidence. The mortality of prostate cancer did not differ significantly by supplement of β-carotene (1 trial), vitamin C (1 trial), vitamin E (2 trials), and selenium (1 trial). This study indicates that antioxidant vitamins and selenium supplement did not reduce the incidence and mortality of prostate cancer; these data provide no support for the use of these supplements for the prevention of prostate cancer .
Epidemiological studies demonstrated that human exposure to methylmercury (MeHg) may contribute to the development and progression of metabolic and cardiovascular disorders. However, the mechanisms involved and the role of selenium (Se) and vitamin E (VE) supplementation in modulating MeHg cardiovascular toxicities remain unclear. The effects of Se and VE supplementation on MeHg-mediated systemic oxidative stress, antioxidant defense, inflammation, and endothelial dysfunction are carried out in an animal model. Male Sprague–Dawley rats were fed a starch-based casein diet or the same diet supplemented with 1 or 3 mg Se/kg diet and with or without 250 or 750 mg VE/kg diet. After 28 days of dietary treatment, rats were gavaged with 0 or 3 mg MeHg/kg BW for 14 consecutive days. Results suggested that exposure to MeHg may increase the risk of cardiovascular disease by decreasing circulating paraoxonase-1 activities, increasing serum oxidized low density lipoprotein levels, and associated systemic inflammation and endothelial dysfunction as reflected by increased leukocyte counts and serum levels of intercellular adhesion molecule-1 and monocyte chemotactic protein-1. Se and VE supplementation may either alleviate or augment the effects of MeHg, depending on their doses and combinations .
The analysis of the hepatotoxic effect of malathion in adult male rats and evaluate the possible hepatoprotective effect of vitamin E and/or selenium. Oral administration of malathion for 45 days significantly induced marked hepatic injury as revealed by increased activity of the plasma enzymes (alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH) and gamma-glutamyl transferase GGT). Oral administration of vitamin E and selenium in combination with malathion exhibited a significant protective effect by lowering the elevated plasma levels of the previous enzymes. Light microscopic investigation revealed that malathion exposure was associated with necrosis of hepatocytes, marked changes of liver tissues in the form of dilated veins, hemorrhagic spots and some degenerative signs of hepatocytes .
Research on Se during the last few years has produced a great deal of evidence demonstrating the important role that Se and its metabolites play in human diseases. In particular, our knowledge of the functional roles of the GPx and TrxR groups as essential antioxidant selenoenzymes in protecting cells from oxidative stress has greatly increased, as has the link between these enzymes and various diseases. However, there are still areas of research that require in-depth study, including the mechanistic modes of action of Se in cancer etiology, how Se delivers its anticancer activity at the molecular and genetic levels, and what biomarkers can be used to accurately measure the efficacy of Se for use in chemoprevention. It is not well understood the specific mechanism by which Se protects cells and tissue at the cellular level from damage due to oxidative stress; this is particularly relevant in heart diseases, which are still a major cause of death worldwide. Given the number of Se cancer preventive trials that are currently being undertaken in many countries, the significant outcomes of these trials will not only provide us with more information on optimal Se intake for the treatment and prevention of cancer, but they will also provide us with strategies in the management of other potential human diseases associated with low Se status. Until the specific biomarkers are identified that will directly link Se with disease prevention and treatment, its use as supplements in health therapy should be taken with caution.
The Selenium and Vitamin E Cancer prevention Trial (SELECT) failed to show an effect in human population. However, pre- and pro-SELECT studies are still supporting the potential usefulness of selenium and/or vitamin E for prevention of prostate cancer and possibly other conditions. Much remains to be understood about the absorption, metabolism and physiologic chemistry of these agents. Nonetheless, the existing evidence supporting selenium and vitamin E as potential prostate cancer chemopreventive agents is possibly enough to justify further efforts in this direction.
My goal in putting this review together was to provide a wide range of subjects dealing with selenium and vitamin E supplementation, that are used in chronic disease prevention, due to their antiradical activities indicating that the combine effects of Se and vitamin E could provide an important dietary source of antioxidants and/or potential agents for a variety of human diseases. It is my hope that readers will find this chapter to be useful in further studies dealing with this subject.
Berzelius, J. J. (1818). Afhandl. Fys. Kemi Minerag. 6, 42
Shamberger R. J. 1984 Selenium Earl Frieden, Ed.; Plenum Press; New York, NY 3 201 237
Brasted R. C. Robert C. Brasted, Ed.; D. Van Nostrand Co.; Princeton, NJ 1961 2
Merian E. Introduction on environmental chemistry and global cycles of chromium, nickel, cobalt beryllium, arsenic, cadmium and selenium, and their derivatives 1984 8 9 38
Smith M. Franke K. W. Westfall B. B. The selenium problem in relation to public health. A preliminary survey to determine the possibility of selenium intoxication in the rural population living in seleniferous soil 1936 51 1496 1505
Thomson C. D. 2004 Assessment of requirements for selenium and adequacy of selenium status: a review 58 391 402
Goldhaber S. B. 2003 Trace element risk assessment vs toxicity 38 232 242
Castellano S. Gladyshev V. N. Guigo R. Berry M. J. 2008 SelenoDB 1.0: a database of selenoprotein genes, proteins and SECIS elements 36 332D 338D
Allmang C. Wurth L. Krol A. The selenium to selenoprotein pathway in eukaryotes: more molecular partners than anticipated 2009 1790 1415 1423
Arbogast S. Ferreiro A. Selenoproteins and protection against oxidative stress selenoprotein N as a novel player at the crossroads of redox signaling and calcium homeostasis 2009 12 893 904
Kipp A. Banning A. Van Schothorst E. M. Meplan C. Schomburg L. Evelo C. Coort S. Gaj S. Keijer J. Hesketh J. Brigelius-Flohe R. 2009 Four selenoproteins, protein biosynthesis, and Wnt signaling are particularly sensitive to limited selenium intake in mouse colon 53 1561 1572
Lescure A. Rederstorff M. Krol A. Guicheney P. Allamand V. Selenoprotein function and muscle disease 2009 1790 1569 1574
Lobinski R. Edmonds J. S. Sukuki K. T. Uden P. C. Species-selective determination of selenium compounds in biological materials 2000 72 447 461
Bleys J. Navas-Acien A. Stranges S. Menke A. Miller E. R. III Guallar E. 2008 Serum selenium and serum lipids in US adults 88 416 423
Johnson C. C. Fordyce F. M. Rayman M. P. 2010 Symposium on “geographical and geological influences on nutrition”: factors controlling the distribution of selenium in the environment and their impact on health and nutrition 69 119 132
Navarro-Alarcon M. Cabrera-Vique C. Selenium in food and the human body: a review 2008 400 115 141
Schrauzer G. N. Surai P. F. 2009 Selenium in human and animal nutrition: resolved and unresolved issues. A partial historical treatise in commemoration of the fiftieth anniversary of the discovery of the biologically essentiality of selenium, dedicated to the memory of Klaus Schwarz (1914-1978) on the occasion of the thirtieth anniversary of his dead 29 2 9
World Health Organization Selenium 1987
Thompson H. J. 2001 Dolph L. Hatfield, Ed.; Kluwer Academic. Publishers; Boston, MA 283 297
Hatfield D. L. 2001 Dolph L. Hatfield, Ed.; Kluwer Academic. Publishers; Boston, MA
Bols M. Lopez O. Ortega-Caballero F. 2007 In Kamerling, J. P., Ed. Elsevier Science: Oxford 1 815 884
Soriano-Garcia M. Organoselenium Compounds as Potential Therapeutic and Chemopreventive Agents: A review 2004 11 1657 1169
Mugesh G. du Mont W.-W. Sies H. 2001 Chemistry of Biologically Important Synthetic Organoselenium Compounds 101 2125 2180
Rayman M. P. 2005 Selenium in cancer prevention: a review of the evidence and mechanism of action 64 527 542
Papp L. V. Holmgren A. Khanna K. K. Selenium and Selenoproteins in Health and Disease 2010 12 793 795
Jablonska E. Gromadzinska J. Sobala W. Reszka E. Wasowicz W. Lung cancer risk associated with selenium status is modified in smoking individuals by Sep15 polymorphism 2008 47 47 54
Kryukov G. V. Castellano S. Novoselov S. V. Lobanov A. V. Zehtab O. Guigo R. et al. Characterization of mammalian selenoproteomes 2003 300 1439 1443
Ashton K. Hooper L. Harvey L. J. Hurst R. Casgrain A. Fairweather-Tait S. J. Methods of assessment of selenium status in humans: a systematic review 2009 89 2025S 2039S
Ip C. Dong Y. Ganther H. E. New concepts in selenium chemoprevention 2002 21 281 289
Schrauzer G. N. 2009 Selenium and selenium-antagonistic elements in nutritional cancer prevention 29 10 17
Evans P. Halliwell B. 2001 Micronutrients: oxidant/antioxidant status 85 67S 74S
Wolf G. The discovery of the antioxidant function of vitamin E: the contribution of Henry A. Matill 2005 135 363 366
Sies H. Murphy M. E. 1991 Role of tocopherols in the protection of biological systems against oxidative damage 8 211 218
Brigelius-Flohe´ R. Traber M. G. 1999 Vitamin E: function and metabolism 13 1145 1155
Yap S. P. Yuen K. H. Wong J. W. 2001 Pharmacokinetics and bioavailability of alpha-, gamma-, and delta-tocotrienols under different food status 53 67 71
Yash B. J. Pratico D. 2012 Vitamin E in aging, dementia and Alzheimer’s disease 38 90 97
Hacquebard M. Carpentier Y. A. 2005 Vitamin E: absorption, plasma transport and cell uptake 8 133 138
O’Byrne D. Grundy S. Packer L. Devaraj S. Baldenius K. Hoppe P. P. Kraemer K. Jialal I. Traber M. G. 2000 Studies of LDL oxidation following alpha-, gamma-, or delta-tocotrienyl acetate supplementation of hypercholesterolemic humans 29 834 845
Horiguchi M. Arita M. Kaempf-Rotzoll D. E. Tsujimoto M. Inoue K. Arai H. p. pH-dependent translocation of alpha-tocopherol transfer protein (alpha-TTP) between hepatic cytosol and late endosomes 2003 8 789 800
Uchida T. Abe C. Nomura S. Ichikawa T. Ikeda S. Tissue distribution of alfa- and gamma- tocotrienol and gama-tocopherol in rats and interference with their accumulation by alpha-tocopherol 2012 47 129 139
Kokarnig S. Kuehnelt D. Stiboller M. Hartleb U. Francesconi K. A. Quantitative determination of small selenium species in human serum by HPLC/ICPMS following a protein-removal, pre-concentration procedure 2011 400 2323 2327
Suzuki K. T. Kurasaki K. Okazaki N. Ogra Y. 2005 Selenosugar, trimethylselenonium among urinary Se metabolites: dose- and agerelated changes 206 1 8
Klotz L. O. Kroncke K. D. Buchczyk D. P. Sies H. 2003 Role of copper, zinc, selenium, tellurium in the cellular defense against oxidative and nitrosative stress 133 1448S 1451S
Valko M. Rhodes C. J. Moncol J. Izakovic M. Mazur M. 2006 Free radicals, metals, antioxidants in oxidative stress-induced cancer 160 1 40
Susan J. F. T. Yongping B. Martin R. B. Rachel C. Dianne F. John E. H. et al. Selenium in human health and disease 2011 14 1337 1383
Pasco J. A. Jacka F. N. Williams L. J. Evans-Cleverdon M. Sharon L. Brennana S. L. Kotowicza M. A. Nicholsone G. C. Ball M. J. Berk M. 2012 Dietary selenium and major depression: a nested case-control study 20 119 123
Maes M. Galecki P. Chang Y. S. Berk M. 2011 A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro) degenerative processes in that illness 35 676 692
Ng F. Berk M. Dean O. Bush A. I. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications 2008 11 851 876
Berk M. Ng F. Dean O. Dodd S. Bush A. I. 2008 Glutathione: a novel treatment target in psychiatry 29 346 351
Herken H. Gurel A. Selek S. Armutcu F. Ozen M. E. Bulut M. et al. 2007 Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment 38 247 252
Sarandol A. Sarandol E. Eker S. S. Erdinc S. Vatansever E. Kirli S. Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidativeantioxidative systems 2007 22 67 73
Whanger P. D. 2001 Selenium and the brain: a review 4 81 97
Machado M. S. Rosa R. M. Dantas A. S. Reolon G. K. Appelt H. R. Braga A. L. et al. 2006 An organic selenium compound attenuates apomorphine-induced stereotypy in mice 410 198 202
Malhi G. S. Berk M. Does dopamine dysfunction drive depression? 2007 433 116 124
Ishrat T. Parveen K. Khan M. M. Khuwaja G. Khan M. B. Yousuf S. et al. Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer’s type 2009 1281 117 127
Cardoso B. R. Ong T. P. Jacob-Filho W. Jaluul O. Freitas M. I. Cozzolino S. M. Nutritional status of selenium in Alzheimer’s disease patients 2010 103 803 806
Finley J. W. Penland J. G. 1998 Adequacy or deprivation of dietary selenium in healthy men: clinical and psychological findings 11 1 27
Mokhber N. Namjoo M. Tara F. Boskabadi H. Rayman M. P. Ghayour-Mobarhan M. et al. Effect of supplementation with selenium on postpartum depression: a randomized doubleblind placebo-controlled trial 2011 24 104 108
ISAAC Steering Committee Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC 1998 351 1225 1232
Allan K. Devereux G. 2011 Diet and asthma: nutrition implication from prevention to treatment 111 258 268
Comhair S. Bhathena P. Farver C. Thunnissen F. Srzurum S. Extracellular glutathione peroxidase induction in asthmatic lungs: evidence for redox regulation of expression in human airway epithelial cells 2001 15 70 78
Horváthovà M. Jahnová E. Gazdik F. Effect of selenium supplementation in asthmatic subjects on the expression of endothelial cell adhesion molecules in culture 1999 69 15 26
Hasselmark L. Malmgren R. Zetterstrom O. Unge G. Selenium supplementation in intrinsic asthma 1993 48 30 36
Picado C. Deulofeu R. Lleonart R. et al. Dietary micronutrients/antioxidants and their relationship with bronchial asthma severity 2001 56 43 49
Shaheen S. Sterne J. Thompson R. Songhurst C. Margetts B. Burney P. Dietary antioxidants and asthma in adults. Population-based case-control study 2001 164 1823 1828
Burney P. Potts J. Makowska J. et al. 2008 A case-control study of the relation between plasma selenium and asthma in European populations: a GAL2EN project [see comment][erratum appears in Allergy. 2008; 63 1647.] 63 865 871
Thomson C. D. Wickens K. Miller J. Ingham T. Lampshire P. MJ Epton Town. G. I. Pattemore P. Crane J. Selenium status and allergic disease in a cohort of New Zealand children 2012 42 560 567
Nogueira C. W. Zeni G. Rocha J. B. Organoselenium and organotellurium compounds: toxicology and pharmacology 2004 104 6255 6285
Silva Avila D. Benedetto A. Au C. Manarin F. Erikson K. Antunes Soares F. Teixeira Rocha J. B. Aschner M. Organotellurium and organoselenium compounds attenuate Mn-induced toxicity in Caenorhabditis elegans by preventing oxidative stress 2012 52 1903 1910
Fetoui H. Mahjoubi-Samet A. Jamoussi K. Ellouze F. Guermazi F. Zeghal N. Energy restriction in pregnant and lactating rats lowers bone mass of their progeny 2006 26 421 426
Moreno-Reyes R. Egrise D. Boelaert M. Goldman S. Meuris S. Iodine deficiency mitigates growth retardation and osteopenia in selenium-deficient rats 2006 136 595 600
Ren F. L. Guo X. Zhang R. L. Wang Sh. J. Zuo H. Zhang Z. T. et al. Effects of selenium and iodine deficiency on bone, cartilage growth plate and chondrocyte differentiation in two generations of rats 2007 15 1171 1177
Pahuja D. N. De Luca H. F. 1982 Thyroid hormone and vitamin D metabolism in the rat 213 293 298
Amaraa I. B. Troudia A. Soudania N. Guermazib F. Zeghala N. Toxicity of methimazole on femoral bone in suckling rats: Alleviation by selenium 2012 64 187 195
UNAIDS. Report on the global AIDS epidemic 2008
Fawzi W. W. Msamanga G. I. Spiegelman D. et al. 2004 A randomized trial of multivitamin supplements and HIV disease progression and mortality 351 23 32
Diamond A. M. Hu J. Y. Mansur D. B. 2001 Glutathione peroxidase and viral replication: Implications for viral evolution and chemoprevention 14 205 210
Pace G. W. Leaf C. D. 1995 The role of oxidative stress in HIV disease 19 523 528
Stone C. A. Kawai K. Kupka R. Fawzi W. W. 2010 Role of selenium in HIV infection. 68 671 681
St Germain D. L. Galton V. A. Hernandez A. 2009 Minireview: Defining the roles of the iodothyronine deiodinases: current concepts and challenges 150 1097 1107
Zhang S. Rocourt C. Cheng W-H. Selenoproteins and the aging brain 2010 13 253 260
Schweizer U. Brauer A. U. Kohrle J. Nitsch R. Savaskan N. E. Selenium and brain function: a poorly recognized liaison 2004 45 164 178
Hock A. Demmel U. Schicha H. Kasperek K. Feinendegen L. E. Trace element concentration in human brain. Activation analysis of cobalt, iron, rubidium, selenium, zinc, chromium, silver, cesium, antimony and scandium 1975 98 49 64
Prohaska J. R. Ganther H. E. 1976 Selenium and glutathione peroxidase in developing rat brain 27 1379 1387
Trapp G. A. Millam J. The distribution of 75Se in brains of selenium-deficient rats 1975 24 593 595
Nakayama A. Hill K. E. Austin L. M. Motley A. K. Burk R. F. All regions of mouse brain are dependent on selenoprotein P for maintenance of selenium 2007 137 690 693
Kyriakopoulos A. Rothlein D. Pfeifer H. Bertelsmann H. Kappler S. Behne D. Detection of small selenium-containing proteins in tissues of the rat 2000 14 179 183
Hawkes W. C. Hornbostel L. Effects of dietary selenium on mood in healthy men living in a metabolic research unit 1996 39 121 128
Ashrafi M. R. Shabanian R. Abbaskhanian A. Nasirian A. Ghofrani M. Mohammadi M. Zamani G. R. Kayhanidoost Z. Ebrahimi S. Pourpak Z. Selenium and Intractable Epilepsy: Is There Any Correlation? 2007 36 25 29
Rayman M. P. 2000 The importance of selenium to human health 356 233 241
Chen J. Berry M. J. Selenium and selenoproteins in the brain and brain diseases 2003 86 1 12
Berry M. J. Banu L. Larsen P. R. 1991 Type I iodothyronine deiodinase is a selenocysteine-containing enzyme 349 438 440
Hill K. E. McCollum G. W. Boeglin M. E. Burk R. F. 1997 Thioredoxin reductase activity is decreased in selenium deficiency 234 293 295
Duntas L. H. 2010 Selenium and the Thyroid: A Close-Knit Connection 95 5180 5188
Hatfield D. L. Yoo M.-H. Carlson B. A. Gladyshev V. N. 2009 Selenoproteins that function in cancer prevention and promotion 1790 1541 1545
Steinbrenner H. Sies H. Protection against reactive oxygen species by selenoproteins 2009 1790 1478 1485
Ip C. Lessons from basic research in selenium and cancer prevention 1998 128 1845 1849
Shamberger R. J. 1970 Relationship of selenium to cancer: inhibitory effect of selenium on carcinogenesis 44 931 936
Clark L. C. Combs G. F. Turnbull B. W. 1996 Effect of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized clinical trial 279 1975 1982
Bjelakovic G. Nikolova D. Simonetti R. G. Gluud C. 2008 Systematic review: primary and secondary prevention of gastrointestinal cancers with antioxidant supplements 28 689 703
Brinkman M. Buntinx F. Muls E. Zeegers M. P. Use of selenium in chemo- prevention of bladder cancer 2006 7 766 774
Lu J. Jiang C. Selenium and cancer chemoprevention: hypotheses integrating the actions of selenoproteins and selenium metabolites in epithelial and non-epithelial target cells 2005 7 1715 1727
Waters D. J. Shen S. Glickman L. T. Cooley D. M. Bostwick D. G. Qian J. et al. Prostate cancer risk and DNA damage: translational significance of selenium supple- mentation in a canine model 2005 26 1256 1562
Battin E. E. Perron N. R. Brumaghim J. L. 2006 The central role of metal coordination in selenium antioxidant acitivity 45 499 501
Rayman M. P. 2009 Selenoproteins and human health: Insights from epidemiological data 1790 1533 1540
Bleys J. Navas-Acien A. Guallar E. Serum selenium and diabetes in US adults 2007 30 829 834
Akbaraly T. N. Arnaud J. Rayman M. P. Hininger-Favier I. Roussel A. M. Berr C. Fontbonne A. Plasma selenium and risk of dysglycemia in an elderly French population: results from the prospective Epidemiology of Vascular Ageing Study 2010 7 21 27
Bleys J. Navas-Acien A. Guallar E. 2007 Selenium and diabetes: more bad news for supplements 147 271 272
Faure P. Ramon O. Favier A. Halimi S. Selenium supplementation decreases nuclear factor-kappa B activity in peripheral blood mononuclear cells from type 2 diabetic patients 2004 34 475 481
Stranges S. Marshall T. R. Natarajan R. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial 2007 147 217 223
Agarwal A. Prabhakaran S. A. 2005 Mechanism, measurement and prevention of oxidative stress in male reproductive physiology 43 963 974
Hansen J. C. Degachi Y. Selenium and fertility in animals and men: a review 1996 37 19 25
Wantanobe T. Endo A. Effects of selenium deficiency on spermmorphology and spermatocyte chromosomes in mice 1991 262 93 96
Olson G. E. Winfrey V. P. Hill K. E. Burk R. F. 2004 Sequential development of flagellar defects in spermatids and epididymal spermatozoa of selenium deficient rats 127 335 341
Lenzi A. Gandini L. Lombardo F. Picardo M. Maresca V. Panfili E. et al. Polyunsaturated fatty acids of germ cell membranes, glutathione and blutathione dependent enzyme-PHGPx: from basic to clinic 2002 65 301 305
Hawkes W. C. Alkan Z. Wong K. Selenium supplementation does not affect testicular selenium status and semen quality in North American men 2009 30 525 533
Seaton A. Godden D. J. Brown K. 1994 Increase in asthma: a more toxic environment or a more susceptible population 49 171 174
University of Maryland. Asthma [Online]. 2011 cited on August 10, 2011]. Available from URL: http://www.umm.edu/altmed/articles/asthma-000015.htm Citation Date= July 4, 2012]
Kloner A. R. Przyklenk K. Whittaker P. Deleterious effects of oxygen radicals in ischaemia-reperfusion: resolved and unresolved issue 1989 80 1115 1127
Prithviraj T. Misra K. P. Reversal of atherosclerosis-fact or fiction? 2000 4 97 100
Sattler W. Maiorino M. Stocker R. 1994 Reduction of HDL and LDL associated cholestrylester and phospholipids hydroperoxides by phospholipids hydroperoxideglutathione peroxidase and ebselen (Pz 51) 309 224
Ricetti M. M. Guidi G. C. Tecchio C. et al. 1999 Effects of sodium selenite on in vitro interactions between platelets and endotelial cells 29 80 82
Kharb S. Low blood glutathione levels in acute myocardial infarction 2003 57 335 337
Riaz M. Mehmood K. T. Selenium in human health and disease: a review 2012 26 120 133
Suleyman Ö. Mustafa N. Mesut Ç. Vedat B. Flores-Arce M. F. Effects of Different Medical Treatments on Serum Copper, Selenium and Zinc Levels in Patients with Rheumatoid Arthritis 2011 142 447 455
Peretz A. Siderova V. Neve J. Selenium supplementation in rheumatoid arthritis investigated in a double blind, placebo- controlled trial 2001 30 208 212
Cunningham F. G. Lindheimer M. D. 1992 Hypertension in Pregnancy: Current concepts 326 927 932
Sharma J. B. 2001 Benefits of Selenium during pregnancy 6 459 462
Barrington J. W. Lindsay P. Names D. Smith S. Robert A. Selenium deficiency and miscarriage: a possible link? 1996 2 130 132
Tinggi U. 2008 Selenium: its role as antioxidant in human health 13 102 108
Beck M. A. 2001 Antioxidants and viral infections: host immune response and viral pathogenicity 20 384S 388S
Beck M. 2006 Selenium, viral infections Hatfield DL, Berry MJ, Gladyshev VN, editors New York: Springer 287 298
Broome C. S. McArdle F. Kyle J. A. Andrews F. Lowe N. M. Hart C. A. et al. 2004 An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status 80 154 162
Baum M. K. Campa A. Role of selenium in HIV/AIDS. In: Hatfield DL, Berry MJ, Gladyshev VN, editors New York: Springer 2006 299 310
McKenzie R. C. Beckett G. J. Arthur J. R. 2006 Effects of selenium on immunity and aging. In: Hatfield DL, Berry MJ, Gladyshev VN editors New York: Springer 287 298
Sheweita S. A. Koshhal K. Calcium metabolism and oxidative stress in bone fractures: role of antioxidants 2007 8 519 525
Finkel T. Holbrook N. J. 2000 Oxidants, oxidative stress and biology of ageing 408 147 239
Cetinus E. Kilinc¸ M. Uzel M. Inanc¸ F. Kurutas E. B. Bilgic E. et al. Does long-term ischemia affect the oxidant status during fracture healing? 2005 125 376 380
Sandukji A. Al-Sawaf H. Mohamadin A. Alrashidi Y. Sheweita S. A. Oxidative stress and bone markers in plasma of patients with long-bone fixative surgery: Role of antioxidants 2010 30 435 442
Azzi A. Aratri E. Boscoboinik D. Clement S. Ozer N. K. Ricciarelli R. Spycher S. 1998 Molecular basis of α-tocopherol control of smooth muscle cell proliferation 7 3 14
Brigelius-Flohe´ R. Galli F. 2010 Vitamin E: A vitamin still awaiting the detection of its biological function. 54 583 587
Cicek N. Eryilmaz O. G. Sarikaya E. Gulerman C. Genc Y. 2012 Vitamin E effect on controlled ovarian stimulation of unexplained infertile women 29 325 328
Khanna S. Parinandi N. L. Kotha S. R. Roy S. Rink C. Bibus D. Sen C. K. 2010 Nanomolar vitamin E alpha-tocotrienol inhibits glutamate-induced activation of phospholipase A2 and causes neuroprotection 112 1249 1260
Reiter E. Jiang Q. Christen S. Anti-inflammatory properties of alpha- and gamma-tocopherol 2007 28 668 691
Naito Y. Shimozawa M. Kuroda M. Nakabe N. Manabe H. Katada K. Kokura S. Ichikawa H. Yoshida N. Noguchi N. Yoshikawa T. Tocotrienols reduce 25-hydroxycholesterol-induced monocyteendothelial cell interaction by inhibiting the surface expression of adhesion molecules 2005 180 19 25
Burlakova E. B. Krashakov S. A. Khrapova N. G. The role of tocopherols in biomembrane lipid peroxidation 1998 12 173 211
Coquette A. Vray B. Vanderpas J. 1986 Role of vitamin E in the protection of the resident macrophage membrane against oxidative damage. Archives Internationales de Physiologie 29S 34S.
Pratico D. Tangirala R. K. Rader D. J. Rokach J. FitzGerald G. A. 1998 Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice 4 1189 1192
Moriguchi S. Muraga M. 2000 Vitamin E and immunity 59 305 336
Wu D. et al. In vitro supplementation with different tocopherol homologues can affect the function of immune cells in old mice 2000 28 643 651
Palamanda J. R. Kehrer J. P. 1993 Involvement of vitamin E and protein thiols in the inhibition of microsomal lipid peroxidation by glutathione 28 427 431
Agarwal A. Sekhon L. H. Oxidative stress and antioxidants for idiopathic oligoasthenoteratospermia: ıs it justified? 2011 27 1 74 85
Bouayed J. Bohn T. 2010 Exogenous antioxidants-double-edged swords in cellular redox state. Health beneficial effects at physiologic doses versus deleterious effects at high doses 3 228 237
Chappell L. C. Seed P. T. Briley A. L. et al. 1999 Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomized trial 354 810 816
Fairfield K. M. Fletcher R. H. 2002 Vitamins for chronic disease prevention in adults: scientific review 287 3116 3126
Forstrom J. W. Zakowski J. J. Tappel A. L. 1978 Identification of the catalytic site of rat liver glutathione peroxidase as selenocysteine 17 2639 2644
Tamura T. Stadtman T. C. 1996 A new selenoprotein from human lung adenocarcinoma cells: purification, properties, and thioredoxin reductase activity 93 1006 1011
Kiremidjian-Schumacher L. Roy M. Wishe H. I. Cohen M. W. Stotzky G. 1994 Supple- mentation with selenium and human immune cell functions. II. Effect on cytotoxic lymphocytes and natural killer cells 41 115 127
Baker S. S. Cohen H. J. 1983 Altered oxidative metabolism in selenium-deficient rat granulocytes 130 2856 2860
Sakaguchi S. et al. Roles of selenium in endotoxin-induced lipid peroxidation in the rats liver and in nitric oxide production in J774A. 1 cells. Toxicology Letters 2000 118 69 77
Kim S. H. Johnson V. J. Shin T. Y. Sharma R. P. 2004 Selenium attenuates lipopoly- saccharide-induced oxidative stress responses through modulation of p38 MAPK and NF-kappaB signaling pathways 229 203 213
Maehira F. Miyagi I. Eguchi Y. Selenium regulates transcription factor NF-kappaB activation during the acute phase reaction 2003 334 163 171
Beck M. A. Matthews C. C. 2000 Micronutrients and host resistance to viral infection 59 581 585
Ip C. Medina D. 1987 Current concepts of selenium and mammary tumorigenesis. Medina D, Kidwell W, Heppner GH, Anderson E, editors New York: Plenum press 479
Ip C. Daniel F. B. Effects of selenium on 7, 12 di-methyl benzanthracene induced mammary carcinogenesis and DNA adduct formation 1985 45 61 68
Lotan Y. Goodman P. J. Youssef R. F. Svatek R. S. Shariat S. F. Tangen C. M. Thompson I. M. Jr. Klein E. A. Evaluation of Vitamin E and Selenium Supplementation for the Prevention of Bladder Cancer in SWOG Coordinated SELECT 2012 187 2005 2010
Jemal A. Siegel R. Xu J. et al. 2010 Cancer statistics 60 277 300
Samanic C. Kogevinas M. Dosemeci M. Malats N. Real F. X. Garcia-Closas M. Serra C. Carrato A. et al. Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender 2006 15 1348 1354
Botteman M. F. Pashos C. L. Redaelli A. et al. The health economics of bladder cancer: a Comprehensive review of the published literature 2003 21 1315 1330
Amaral A. F. S. Cantor K. P. Silverman D. T. Malats N. Selenium and bladder cancer risk: a meta-analysis 2010 19 2407 2415
Bardia A. Tleyjeh I. M. Cerhan J. R. et al. Efficacy of antioxidant supplementation in reducing primary cancer incidence and mortality: systematic review and meta-analysis 2008 83 23 34
Lippman S. M. et al. 2009 Effect of selenium and vitamin E on risk prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). 301 39 51
Ledesma M. C. Jung-Hynes B. Schmit T. L. Kumar R. Mukhtar H. Ahmad N. Selenium and vitamin E for prostate cancer: Post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) status 2011 17 134 143
Beck M. A. 2007 Selenium and vitamin E Status: Impact on viral pathogenicity 137 1338 1340
Jiang L. Yang K-h. Tian J-h. et al. Efficacy of Antioxidant Vitamins and Selenium Supplement in Prostate Cancer Prevention: A Meta-Analysis of Randomized Controlled Trials 2010 62 719 727
Jin X. Hidiroglou N. Lok E. Taylor M. Kapal K. et al. 2012 Dietary Selenium (Se) and Vitamin E (VE) Supplementation Modulated Methylmercury-Mediated Changes in Markers of Cardiovascular Diseases 12 10 24
El-Desoky G. Abdelreheem M. AL-Othman A. Alothman Z. Mahmoud M. Yusuf K. 2012 Potential hepatoprotective effects of vitamin E and selenium on hepatotoxicity induced by malathion in rats 6 806 813